Cargando…

CariesCare International adapted for the pandemic in children: Caries OUT multicentre single-group interventional study protocol

BACKGROUND: Comprehensive caries care has shown effectiveness in controlling caries progression and improving health outcomes by controlling caries risk, preventing initial-caries lesions progression, and patient satisfaction. To date, the caries-progression control effectiveness of the patient-cent...

Descripción completa

Detalles Bibliográficos
Autores principales: Martignon, Stefania, Cortes, Andrea, Douglas, Gail V. A., Newton, J. Timothy, Pitts, Nigel B., Avila, Viviana, Usuga-Vacca, Margarita, Gamboa, Luis F., Deery, Christopher, Abreu-Placeres, Ninoska, Bonifacio, Clarisa, Braga, Mariana M., Carletto-Körber, Fabiana, Castro, Patricia, P. Cerezo, María, Chavarría, Nathaly, Cifuentes, Olga L., Echeverri, Beatriz, Jácome-Liévano, Sofía, Kuzmina, Irina, Lara, J. Sebastián, Manton, David, Martínez-Mier, E. Angeles, Melo, Paulo, Muller-Bolla, Michèle, Ochoa, Emilia, Osorio, Jesús R., Ramos, Ketty, Sanabria, Angie F., Sanjuán, Johanna, San-Martín, Magdalena, Squassi, Aldo, Velasco, A. Karina, Villena, Rita, Zandona, Andrea Ferreira, Beltrán, Edgar O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248759/
https://www.ncbi.nlm.nih.gov/pubmed/34210281
http://dx.doi.org/10.1186/s12903-021-01674-1
Descripción
Sumario:BACKGROUND: Comprehensive caries care has shown effectiveness in controlling caries progression and improving health outcomes by controlling caries risk, preventing initial-caries lesions progression, and patient satisfaction. To date, the caries-progression control effectiveness of the patient-centred risk-based CariesCare International (CCI) system, derived from ICCMS™ for the practice (2019), remains unproven. With the onset of the COVID-19 pandemic a previously planned multi-centre RCT shifted to this “Caries OUT” study, aiming to assess in a single-intervention group in children, the caries-control effectiveness of CCI adapted for the pandemic with non-aerosols generating procedures (non-AGP) and reducing in-office time. METHODS: In this 1-year multi-centre single-group interventional trial the adapted-CCI effectiveness will be assessed in one single group in terms of tooth-surface level caries progression control, and secondarily, individual-level caries progression control, children’s oral-health behaviour change, parents’ and dentists’ process acceptability, and costs exploration. A sample size of 258 3–5 and 6–8 years old patients was calculated after removing half from the previous RCT, allowing for a 25% dropout, including generally health children (27 per centre). The single-group intervention will be the adapted-CCI 4D-cycle caries care, with non-AGP and reduced in-office appointments’ time. A trained examiner per centre will conduct examinations at baseline, at 5–5.5 months (3 months after basic management), 8.5 and 12 months, assessing the child’s CCI caries risk and oral-health behaviour, visually staging and assessing caries-lesions severity and activity without air-drying (ICDAS-merged Epi); fillings/sealants; missing/dental-sepsis teeth, and tooth symptoms, synthetizing together with parent and external-trained dental practitioner (DP) the patient- and tooth-surface level diagnoses and personalised care plan. DP will deliver the adapted-CCI caries care. Parents’ and dentists’ process acceptability will be assessed via Treatment-Evaluation-Inventory questionnaires, and costs in terms of number of appointments and activities. Twenty-one centres in 13 countries will participate. DISCUSSION: The results of Caries OUT adapted for the pandemic will provide clinical data that could help support shifting the caries care in children towards individualised oral-health behaviour improvement and tooth-preserving care, improving health outcomes, and explore if the caries progression can be controlled during the pandemic by conducting non-AGP and reducing in-office time. Trial registration: Retrospectively-registered-ClinicalTrials.gov-NCT04666597-07/12/2020: https://register.clinicaltrials.gov/prs/app/action/SelectProtocol?sid=S000AGM4&selectaction=Edit&uid=U00019IE&ts=2&cx=uwje3h. Protocol-version 2: 27/01/2021. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12903-021-01674-1.